GENinCode’s £17 Million Initial Public Offering

Addleshaw Goddard advised GENinCode. Specialising in cardiovascular disease risk assessment, GENinCode’s products combine genetic and clinical data to risk assess patients and provide doctors with advanced…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here